Product NDC: | 13267-123 |
Proprietary Name: | Fludeoxyglucose F18 |
Non Proprietary Name: | Fludeoxyglucose F18 |
Active Ingredient(s): | 300 mCi/mL & nbsp; Fludeoxyglucose F18 |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 13267-123 |
Labeler Name: | THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021870 |
Marketing Category: | NDA |
Start Marketing Date: | 20050819 |
Package NDC: | 13267-123-23 |
Package Description: | 17 mL in 1 VIAL, GLASS (13267-123-23) |
NDC Code | 13267-123-23 |
Proprietary Name | Fludeoxyglucose F18 |
Package Description | 17 mL in 1 VIAL, GLASS (13267-123-23) |
Product NDC | 13267-123 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Fludeoxyglucose F18 |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20050819 |
Marketing Category Name | NDA |
Labeler Name | THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH |
Substance Name | FLUDEOXYGLUCOSE F-18 |
Strength Number | 300 |
Strength Unit | mCi/mL |
Pharmaceutical Classes | Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] |